Schering Generic Ribavirin Carries PEG-Intron Indication; Valeant Will Receive Royalties

Schering generic launches April 8, two days after FDA clears Three Rivers’ and Sandoz’ ribavirin ANDAs. All generics are expected to be priced at a 10% discount to Schering’s Rebetol.